Biome Analytics, a leader in cardiovascular performance analytics, announces the launch of its newest module designed to enhance data-driven decision-making for ECMO, heart transplant, and LVAD ...

Developed in collaboration with leading transplant and mechanical circulatory support (MCS) centers ... financial outcomes. “As ECMO, heart transplant, and LVAD programs grow in complexity ...

BOSTON, MA—While the medical community awaits updated guidelines on the use of mechanical circulatory support (MCS) following the DanGer Shock ... the trial showed that routine use of the Impella CP ...

New Delhi: A top Army hospital in Delhi has performed India's "first-ever" left ventricular assist device (LVAD) implantation using a cutting-edge device at a government institution, the defence ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

The goal of the trial was to evaluate treatment with an Impella percutaneous left ventricular assist device (LVAD) compared with an intra-aortic balloon pump (IABP) in patients with cardiogenic ...

Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the ...

Biome Analytics, a leader in cardiovascular performance analytics, announces the launch of its newest module designed to enhance data-driven decision-making for ECMO, heart transplant, and LVAD ...